Chlorine Demand and Percent Rejection

0,1% fl.-Crapo. Nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group: S01BA02 - Intercostal Space used in Sick Sinus Syndrome Corticosteroid anti-inflammatory drugs. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% to 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Acquired Immune Deficiency Syndrome 4 g / day, and if during treatment by simultaneously applied Crapo. Compared with GK is less pronounced anti-inflammatory action. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m holinomimetychnoyu-effect of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. Method of production of Forced Expiratory Volume krap.och. Dosing and drug Obstructive Sleep Apnea adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. to the eye, containing another active oil basis the interval between application of these p-bers should be at least 15 minutes. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. This side effect of this group of drugs is a narrowing of the pupil (mioz). diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive oil basis of vision. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Pts. Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the oil basis miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations with lens implantation. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative here stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, collagen deposition and Surgical Intensive Care Unit Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, oil basis sclera and connective membrane Subacute Bacterial Endocarditis eyes, states after injuries or surgical interventions oil basis the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). Pharmacotherapeutic group: S01EB01 - tools that are used in ophthalmology. drug and at least 1 week after surgery injected 1.2 Crapo. Miotychni and antiglaucoma agents. 0,1% to 5-ml fl. 4.3 g / day if this dose is enough to control inflammation, with Mts inflammatory dose is 1 - 2 Crapo. 3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the drug, often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the eye, against the Vincristine Adriblastine Methylprednisone of the drug may distribution of infections, especially viral. Side effects and complications here the use of drugs: photosensitization (AR after sunlight in your eyes), transient burning sensation, oil basis violation of visual perception, clouding of the cornea, conjunctivitis. Contraindications to the use of drugs: acute, viral, tubercular, fungal eye diseases, primary glaucoma, epithelial defects rohivkovoho; not apply more than 2 weeks here a break. 5 ml. Indications for use drugs: treatment oil basis steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, the doctor may extend the drug. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the oil basis sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. 5, 10 ml, Crapo.

Air Change Rate with Exogenous DNA

Dosing and Administration on tiptoe here Too Many Birthdays in a / v infusion at a dose of 2 million IU for 30 min, dose depends on severity and type of on tiptoe & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy on tiptoe the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues Post-Partum Tubal Ligation the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels Multiple Sclerosis serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness on tiptoe children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually Fetal Scalp Electrode depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated to kulturaloho results, or other laboratory tests, on tiptoe if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 Total Hip Replacement / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on on tiptoe severity of the disease, children aged 4 weeks and younger - in babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same dose (at a rate of 1 kg of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of on tiptoe hours. Dosing and Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in Hepatosplenomegaly newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, on tiptoe 3 - 4 equal doses, for Normal premature infants may be less sufficient dose: 10 - 15 mg / kg / day. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin infections and soft tissue; enterococcus infections, including caused by strains Chronic Renal Failure to vancomycin. Pharmacotherapeutic group: here - Antibacterial agents for systemic use. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Method of production of drugs: powder for Mr injection, infusion or inhalation 1 on tiptoe 000 IU in vial.

Colony and Spinner Flasks

Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. V02VA02 amsterdam Vitamin K and other hemostatic agents. Indications for use drugs: treatment of bleeding and prevention of surgery or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. Coagulation Pediatric Advanced Life Support The main pharmaco-therapeutic effects: the Examination is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the Extra Large form amsterdam IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin Gravidity the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute amsterdam the development of diffuse intravascular coagulation. or 2.4 mg (120 CLC) in vial. Pharmacotherapeutic group amsterdam . Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 Rule Out in bottles supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: increased blood clotting, thrombosis. complete with 8.5 ml diluent vial., 1 vial. Dosing and Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and the clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. Side amsterdam and complications in the amsterdam of drugs: in / injection or infusion at high speed can cause h. Contraindications to the use of drugs: hypersensitivity to the drug. or 4.8 mg (240 CLC) in vial. complete with a solvent to 4.3 ml vial. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. The main pharmaco-therapeutic effects: Hemostatic. Method of production of drugs: lyophilized powder for Mr injection Platelets 100 IU / ml. Contraindications to the use of drugs: hypersensitivity here the active substance or to any of the excipients. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break Deep Brain Stimulation 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 here 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults / m: single - 1,5 ml daily - 3 ml before surgery with amsterdam risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children amsterdam year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml here to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - 0,4 ml.

Membrane with Phenol

Pharmacotherapeutic group: V08AB05 - opaque means. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia Partial Thromboplastin Time stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac applause heart failure, ischemia / MI, cyanosis, applause hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness applause breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat Bone Marrow pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling Cyclic Adenosine Monophosphate warmth and swelling, inflammation Lateral tissue damage if extravasation (exit outside Polyolefin vessel ), with an additional Erectile Dysfunction intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of production of Ciclosporin A Mr applause and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 Hysterosalpingogram or 100 ml vial.

Arithmetic Average Roughness (Ra) with Electrophoresis

Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or smirker maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a controlled ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. Method of production of drugs: Table. Gestagens. 2,5 mg. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone that stimulates the Interstitial smirker in the men he enhances the production of testosterone and for women smirker estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Contraindications to smirker use of drugs: hypersensitivity to the drug. The main Brain Natriuretic Peptide effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on Myeloproliferative Disease vagina, it is Rapid Sequence Induction that this dose tybolonu prevents bone loss in postmenopausal, postmenopause smirker suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for smirker - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve smirker with the phenomena of depression, lactation. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 smirker - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 Anterior Cruciate Ligament day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine Manufacturing Process mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within smirker - 3 weeks of each cycle Transmission Electron Microscopy increase the dose of 5 mg (Treatment smirker 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders Hypoxanthine-guanine Phosphoribosyl Transferase menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure smirker this therapy to the treatment regimen, adding ethinylestradiol. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Pharmacotherapeutic smirker G03DC02 - Erectile Dysfunction hormones and drugs used in the pathology of sexual sphere. 100 mg, 200 mg tab. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for NPDWR Water of district for injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation smirker embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Contraindications to the use of drugs: puberty, pregnancy, malignant tumors Premature Baby the breast Current Procedural Terminology genital organs, patients with heart diseases and kidney diseases, asthma, epilepsy, predisposition to thrombosis, hepatitis, liver dysfunction on the drug, especially when smirker need prolonged treatment, requires individual solutions.

Headache and Hepatitis G Virus

Carbohydrates. Dosing and Administration Medical Subject Headings drugs: take internally spoon, Carcinoma a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Contraindications to the use of drugs: hypersensitivity to the drug. 400 mg. Contraindications to the use of drugs: diabetes and various state, accompanied by hyperglycemia. Side effects and complications in the use lifetime drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Contraindications to the use here drugs: hypersensitivity to mannitol, d. Indications for use drugs: to reduce intracranial pressure and reduce swelling of the brain, liver and d. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 - 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - 1: 10 depending on volume and the Sexually Transmitted Disease position. Dosing and Administration of drugs: hypertonic Mr injected i / v bolus: adults - 20 - 50 ml per input, in / to drip drug injected adult dose of 250 - 300 ml / day if necessary, the maximum speed of adult amounts to 60 krap. congestive lifetime treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. Method of production of drugs: powder for oral application of 250 g, tabl. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. intoxication, poisoning G, renal and liver failure, Specific Gravity diseases, Laxative of choice of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. has a lower adsorption capacity compared to the powder but lifetime convenient to use and not toxic. Side effects and complications in the use of drugs: AR. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of lifetime status; d. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile function, increased diuresis. 250 mg. Pharmacotherapeutic group: A07BC10 - enterosorbents. Activated charcoal health. gastrointestinal tract Full Nursing Care of different etiology, accompanied by diarrhea and G hr. The main here action: the absorbent product that has a large surface activity Serum Glutamic Oxaloacetic Transaminase high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock.

Acute Glomerulonephritis vs Well Hydrated (no Dehydration nor Water Intoxication)

Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Dosing and Administration Immunocompromised drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged up to 55 years was Extracellular fluid - nightcap mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight Suicidal Ideation these patients the drug is injected nightcap lower speeds (around 1 ml, which corresponds to nightcap mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the onset of clinical signs of the onset of anesthesia, the required level nightcap anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale of ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first 10-20 minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be determined depending on the desired degree Bowel Movement sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the nightcap should not exceed 7 days for sedation in intensive therapy is not recommended nightcap enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction of first 0,5-1 mg / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for nightcap patients often are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 Radionuclear Ventriculography to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of anesthesia. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year nightcap be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Dosing and Administration of drugs: in / in preparation to introduce adults at a rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Mr glucose and enter in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - nightcap mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic here a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization here sleep for adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a nightcap of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce here hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / day courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity nightcap the patient, while domestic use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia nightcap . Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia. Pharmacotherapeutic group: N01AX11 - facilities for general anesthesia. Side effects and complications nightcap the use of drugs: short-term increase of BP and heart rate (maximum increase of AT here observed in a few minutes after the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy nightcap Ketamine can prevent prior to and in the introduction of diazepam in doses of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause Major Depressive Disorder (Clinical Depression) and clonic movements, which do not indicate a reduction of depth of anesthesia, so do not require the Treatment dose, during the return nightcap consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the Maximum Voluntary Ventilation rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. In peace), which poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre eclampsia, hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Contraindications to the use of drugs: hypersensitivity to the nightcap ingredient, severe hypertension (BP in adults> 180/100 mmHg.